These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Biochemical screening of congenital developmental abnormalities using determination of fetoplacental antigens. Fialová L; Malbohan I; Mikulíková L; Hájek Z Acta Univ Carol Med (Praha); 1993; 39(1-4):3-8. PubMed ID: 9355657 [TBL] [Abstract][Full Text] [Related]
12. [Study on key techniques and intervention in reducing birth defects]. Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989 [TBL] [Abstract][Full Text] [Related]
14. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases]. Arbuzova SB; Nikolenko MI Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526 [TBL] [Abstract][Full Text] [Related]
16. Prenatal screening for neural tube defects in South Africa. An assessment. Grace HJ S Afr Med J; 1981 Aug; 60(8):324-9. PubMed ID: 6789464 [TBL] [Abstract][Full Text] [Related]
17. Maternal alpha-fetoprotein screening: two years' experience in a low-risk district. Standing SJ; Brindle MJ; Macdonald AP; Lacey RW Br Med J (Clin Res Ed); 1981 Sep; 283(6293):705-7. PubMed ID: 6169386 [TBL] [Abstract][Full Text] [Related]
18. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Milunsky A; Jick SS; Bruell CL; MacLaughlin DS; Tsung YK; Jick H; Rothman KJ; Willett W Am J Obstet Gynecol; 1989 Aug; 161(2):291-7. PubMed ID: 2475017 [TBL] [Abstract][Full Text] [Related]